This study is designed to evaluate the effectiveness of adding Etanercept to disease modifying anti-rheumatic drug (DMARD) therapy in subjects with moderately active Rheumatoid Arthritis (RA).
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01313208?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
